Editor's Picks

There is no pinned content in this Editor's Picks module.
Click here to learn more about content pinning.

Alkermes, Inc.

  1. Alkermes Files Resale Shelf Registration in Connection with Elan Shareholder Agreement
    Street Insider 1 day ago

    These securities may not be sold nor may offers to buy be accepted prior to the time the Registration Statement becomes effective. This announcement is neither an offer to sell nor a solicitation of an offer to buy ordinary shares. Alkermes plc is a...

  2. The Zacks Analyst Blog Highlights: Charles Schwab, E*TRADE Financial, TD Ameritrade Holding, Amylin Pharmaceuticals and Alkermes plc
    PR Newswire logo PR Newswire 1 day ago

    Stocks recently featured in the blog include Charles Schwab Corp. (NYSE: SCHW), E*TRADE Financial Corporation (Nasdaq: ETFC), TD Ameritrade Holding Corporation (Nasdaq: AMTD), Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Alkermes plc (Nasdaq: ALKS).

  3. Amylin's Bydureon Launches in the US - Analyst Blog
    NASDAQ 2 days ago

    Pharmaceuticals, Inc. Bydureon, a glucagon-like peptide-1 (GLP-1) receptor agonist, gained approval earlier this year as an adjunct to diet and exercise to improve glycemic control in adults with type II diabetes. This means that Bydureon can be used...

  4. Video: Biotech Outperforms Broader Market
    MSNBC logo MSNBC 3 days ago
    NULL

    The S&P biotech index is up 13% so far this year. Richard Pops, Alkermes chairman & CEO, offers insight on what's behind the biotech surge. Related Links: Business & financial news headlines from msnbc.com Top of page

  5. Amylin, Alkermes announce availability of Bydureon in US
    Pharmaceutical Business Review 3 days ago

    Nanotechnology in Drug Delivery - Technological Improvements and Novel Approaches to Fulfill High Potential GBI Research, the leading business intelligence provider, has released its latest report, “Nanotechnology in Drug Delivery - Technological...

  6. Charts of the Day - ALKS, AMLN, RINO, ZOLT - Stock Charts Harry Boxer, TheTechTrader.com
    YouTube Logo YouTube Videos 23 months ago
  7. BYDUREON™, First and Only Once-Weekly Type 2 Diabetes Treatment, Now Available in U.S. Pharmacies
    PR Newswire logo PR Newswire 4 days ago

    (Nasdaq: AMLN) and Alkermes plc (Nasdaq: ALKS) today announced that BYDUREON™ (exenatide extended-release for injectable suspension) is now available by prescription in U.S. pharmacies. The U.S. Food and Drug Administration (FDA) approved BYDUREON, the...

  8. Acorda Therapeutics Names Jane Wasman as Chief, Strategic Development
    Business Wire logo Business Wire 4 days ago

    This was demonstrated by an improvement in walking speed. AMPYRA is marketed outside the United States as FAMPYRA® (prolonged-release fampridine tablets) by Biogen Idec under a licensing agreement from Acorda. AMPYRA and FAMPYRA are manufactured under...

(What's this?)
  1. Are you a Publisher?

    We built Daylife.com using Daylife platform, which helps you be more efficient and creative with content. It's designed for publishers, editors, and developers to build better content-based sites, services, and apps for clients and audiences. Learn More »

About Alkermes, Inc.

Wikipedia

Alkermes, Inc. NASDAQ: ALKS is a pharmaceutical company headquartered in Cambridge, Massachusetts with manufacturing facilities in Wilmington, Ohio and Chelsea, Massachusetts. Alexander Rich, MD is the founder and director since 1987. The company focuses on drug delivery technologies, including "long-acting" or "extended release" formulations of... Full Article

Related Photos

Related Topics

  1. NASDAQ NASDAQ
  2. U.S. Congress U.S. Congress
  3. Elan Corporation plc Elan Corporation plc
  4. Michael J. Fox Michael J. Fox
  5. Diabetes Diabetes
  6. Boehringer Ingelheim Boehringer Ingelheim

Timeline of Coverage

  1. Click to see all coverage from Jan 02, 2012
    0
    January 02, 2012
  2. Click to see all coverage from Jan 03, 2012
    2
    January 03, 2012
  3. Click to see all coverage from Jan 04, 2012
    6
    January 04, 2012
  4. Click to see all coverage from Jan 05, 2012
    2
    January 05, 2012
  5. Click to see all coverage from Jan 06, 2012
    2
    January 06, 2012
  6. Click to see all coverage from Jan 07, 2012
    0
    January 07, 2012
  7. Click to see all coverage from Jan 08, 2012
    0
    January 08, 2012
  8. Click to see all coverage from Jan 09, 2012
    1
    January 09, 2012
  9. Click to see all coverage from Jan 10, 2012
    0
    January 10, 2012
  10. Click to see all coverage from Jan 11, 2012
    1
    January 11, 2012
  11. Click to see all coverage from Jan 12, 2012
    0
    January 12, 2012
  12. Click to see all coverage from Jan 13, 2012
    0
    January 13, 2012
  13. Click to see all coverage from Jan 14, 2012
    0
    January 14, 2012
  14. Click to see all coverage from Jan 15, 2012
    0
    January 15, 2012
  15. Click to see all coverage from Jan 16, 2012
    0
    January 16, 2012
  16. Click to see all coverage from Jan 17, 2012
    0
    January 17, 2012
  17. Click to see all coverage from Jan 18, 2012
    0
    January 18, 2012
  18. Click to see all coverage from Jan 19, 2012
    0
    January 19, 2012
  19. Click to see all coverage from Jan 20, 2012
    0
    January 20, 2012
  20. Click to see all coverage from Jan 21, 2012
    0
    January 21, 2012
  21. Click to see all coverage from Jan 22, 2012
    0
    January 22, 2012
  22. Click to see all coverage from Jan 23, 2012
    0
    January 23, 2012
  23. Click to see all coverage from Jan 24, 2012
    0
    January 24, 2012
  24. Click to see all coverage from Jan 25, 2012
    2
    January 25, 2012
  25. Click to see all coverage from Jan 26, 2012
    4
    January 26, 2012
  26. Click to see all coverage from Jan 27, 2012
    26
    January 27, 2012
  27. Click to see all coverage from Jan 28, 2012
    6
    January 28, 2012
  28. Click to see all coverage from Jan 29, 2012
    1
    January 29, 2012
  29. Click to see all coverage from Jan 30, 2012
    5
    January 30, 2012
  30. Click to see all coverage from Jan 31, 2012
    1
    January 31, 2012
  31. Click to see all coverage from Feb 01, 2012
    6
    February 01, 2012
  32. Click to see all coverage from Feb 02, 2012
    2
    February 02, 2012
  33. Click to see all coverage from Feb 03, 2012
    6
    February 03, 2012
  34. Click to see all coverage from Feb 04, 2012
    0
    February 04, 2012
  35. Click to see all coverage from Feb 05, 2012
    0
    February 05, 2012
  36. Click to see all coverage from Feb 06, 2012
    6
    February 06, 2012
  37. Click to see all coverage from Feb 07, 2012
    1
    February 07, 2012
  38. Click to see all coverage from Feb 08, 2012
    4
    February 08, 2012
  39. Click to see all coverage from Feb 09, 2012
    4
    February 09, 2012
  40. Click to see all coverage from Feb 10, 2012
    0
    February 10, 2012
  41. Click to see all coverage from Feb 11, 2012
    0
    February 11, 2012
  42. Click to see all coverage from Feb 12, 2012
    0
    February 12, 2012
  43. Click to see all coverage from Feb 13, 2012
    4
    February 13, 2012
  44. Click to see all coverage from Feb 14, 2012
    3
    February 14, 2012
  45. Click to see all coverage from Feb 15, 2012
    1
    February 15, 2012
  46. Click to see all coverage from Feb 16, 2012
    6
    February 16, 2012
  47. Click to see all coverage from Feb 17, 2012
    0
    February 17, 2012
  48. Click to see all coverage from Feb 18, 2012
    0
    February 18, 2012

Related Videos

  1. Videosurf
    1. Chart of the Day - ALKS, AMLN, RINO, ZOLT - Stock Charts Harry Boxer, thetechtrader.com
      Chart of the Day - ALKS, AMLN, RINO, ZOLT - Sto...
    2. Charts of the day - CBPO, DJSP, PXLW, XRTX - Stock Charts - Harry Boxer, TheTechTrader.com
      Charts of the day - CBPO, DJSP, PXLW, XRTX - St...
    3. Make Money Online Trading Stock Symbol ALKS 20080314
      Make Money Online Trading Stock Symbol ALKS 200...
    View All Videosurf Videos »

Related Quotes

There are no results for this module. Edit the module to change the search term used to query related quotes.

We found no quotes related to Alkermes, Inc..